A Study of a Single Dose of ASP3291 in Subjects With Mild to Moderately Active Ulcerative Colitis



Status:Archived
Conditions:Colitis, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:August 2010
End Date:October 2011

Use our guide to learn which trials are right for you!

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of ASP3291 Following a Single Oral Dose in Subjects With Mild to Moderately Active Ulcerative Colitis


The purpose of this study is to determine the pharmacokinetics (PK) and to assess safety and
tolerability of a single dose of ASP3291 in subjects with mild to moderately active
ulcerative colitis.


After an 11-day screening period, subjects check into a clinic, are dosed on Day 1 and stay
in the clinic for 4 days to monitor pharmacokinetic and safety parameters.


We found this trial at
3
sites
7940 Floyd Curl Dr.
San Antonio, Texas 78229
210-949-0122
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Anaheim, California 92801
?
mi
from
Anaheim, CA
Click here to add this to my saved trials
Baltimore, Maryland 21201
?
mi
from
Baltimore, MD
Click here to add this to my saved trials